Dose- and time-dependent glucocorticoid receptor signaling in podocytes

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 4, 2010, Pages

  Guess, Adam ^a   Agrawal, Shipra ^a   Wei, Chang Ching ^a   Ransom, Richard F ^a,b   Benndorf, Rainer ^a,b   Smoyer, William E ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Dexamethasone; FKBP51; Nephrotic syndrome

Indexed keywords

ALPHA CRYSTALLIN; BETA ACTIN; BETA CRYSTALLIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOPHILIN; MESSENGER RNA; SULFOTRANSFERASE 1A1; SYNAPTOPODIN; GLUCOCORTICOID;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFICACY; DRUG MECHANISM; ELECTROPHORESIS; FEMALE; GENE TRANSLOCATION; INTRACELLULAR SIGNALING; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TIMED DRUG RELEASE; WESTERN BLOTTING; ANIMAL; ANIMAL MODEL; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; GLOMERULUS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME;

ANIMALS; CELL LINE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; KIDNEY GLOMERULUS; MICE; MODELS, ANIMAL; PODOCYTES; RATS; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 77957989342     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00161.2010     Document Type: Article

References (45)

1. Aoyama A, Fröhli E, Schäfer R, Klemenz R. αB-Crystallin expression in mouse NIH 3T3 fibroblasts: glucocorticoid responsiveness and involvement in thermal protection. Mol Cell Biol 13: 1824-1835, 1993.
2. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Pütz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Künzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Köhnlein O, Dabitz H, Brückl T, Müller N, Pfister H, Lieb R, Mueller JC, Lõhmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36: 1319-1325, 2004.
3. Davies TH, Ning YM, Sánchez ER. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry 44: 2030-2038, 2005.
4. Duanmu Z, Kocarek TA, Runge-Morris M. Transcriptional regulation of rat hepatic aryl sulfotransferase (SULT1A1) gene expression by glucocorticoids. Drug Metab Dispos 29: 1130-1135, 2001. (Pubitemid 32660532)
5. Gambertoglio JG, Frey FJ, Holford NH, Birnbaum JL, Lizak PS, Vincenti F, Feduska NJ, Salvatierra O Jr, Amend WJ Jr. Prednisone and prednisolone bioavailability in renal transplant patients. Kidney Int 21: 621-626, 1982.
6. Hari P, Bagga A, Mantan M. Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome. Indian Pediatr 41: 993-1000, 2004. (Pubitemid 39425311)
7. Harrell JM, Murphy PJ, Morishima Y, Chen H, Mansfield JF, Galigniana MD, Pratt WB. Evidence for glucocorticoid receptor transport on microtubules by dynein. J Biol Chem 279: 54647-54654, 2004. (Pubitemid 40053208)
8. Hirano S, Sun X, DeGuzman CA, Ransom RF, McLeish KR, Smoyer WE, Shelden EA, Welsh MJ, Benndorf R. p38 MAPK/HSP25 signaling mediates cadmium-induced contraction of mesangial cells and renal glomeruli. Am J Physiol Renal Physiol 288: F1133-F1143, 2005. (Pubitemid 40677083)
9. Hodson EM, Craig JC. Therapies for steroid-resistant nephrotic syndrome. Pediatr Nephrol 23: 1391-1394, 2008.
10. Kalimi MY, Agarwal MK. Interaction of antiglucocorticoid RU 486 with rat kidney glucocorticoid receptor. Biochem Biophys Res Commun 153: 365-371, 1988.
11. Kumar R, Calhoun WJ. Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation. Biologics 2: 845-854, 2008.
12. Longui CA. Glucocorticoid therapy: minimizing side effects. J Pediatr (Rio J) 83, Suppl: S163-S177, 2007.
13. Mahajan DK, London SN. Mifepristone (RU486): a review. Fertil Steril 68: 967-976, 1997.
14. Makkonen H, Kauhanen M, Paakinaho V, Jääskeläinen T, Palvimo JJ. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res 37: 4135-4148, 2009.
15. Malcher-Lopes R, Franco A, Tasker JG. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch. Eur J Pharmacol 583: 322-339, 2008.
16. Mendoza SA, Tune BM. Management of the difficult nephrotic patient. Pediatr Clin North Am 42: 1459-1468, 1995.
17. Moore RA. Number of glomeruli in kidney of adult white rat unilaterally nephrectomized in early life. J Exp Med 50: 709-712, 1929.
18. Mundel P, Heid HW, Mundel TM, Krüger M, Reiser J, Kriz W. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139: 193-204, 1997. (Pubitemid 27444091)
19. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, Kriz W, Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997. (Pubitemid 27452369)
20. Pfaffl MW, Lange IG, Daxenberger A, Meyer HH. Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR. APMIS 109: 345-355, 2001. (Pubitemid 32640882)
21. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 228: 111-133, 2003. (Pubitemid 36187918)
22. Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE. Glucocorticoids protect and enhance recovery of cultured murine podocytes against injury via actin filament stabilization. Kidney Int 68: 2473-2483, 2005.
23. Ransom RF, Vega-Warner V, Smoyer WE, Klein J. Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int 67: 1275-1285, 2005. (Pubitemid 40463104)
24. Riggs DL, Cox MB, Tardif HL, Hessling M, Buchner J, Smith DF. Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling. Mol Cell Biol 27: 8658-8669, 2007.
25. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D, Smith DF. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J 22: 1158-1167, 2003. (Pubitemid 36313599)
26. Searle M, Lawson G, Chakraborty J, Baylis EM, Lee HA, Marks V. High-dose methylprednisolone sodium succinate (pulse therapy) in the treatment of renal disease: plasma and urine concentrations. Eur J Clin Pharmacol 28: 245-248, 1985.
27. Sinha A, Bagga A. Pulse steroid therapy. Indian J Pediatr 75: 1057-1066, 2008.
28. Smoyer WE, Ransom RF. Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction. FASEB J 16: 315-326, 2002.
29. Smoyer WE, Ransom RF, Harris RC, Welsh MJ, Lutsch G, Benndorf R. Ischemic acute renal failure induces differential expression of small heat shock proteins. J Am Soc Nephrol 11: 211-221, 2000.
30. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 4: 525-533, 2008.
31. Tasker JG, Di S, Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 147: 5549-5556, 2006.
32. Tatro ET, Everall IP, Kaul M, Achim CL. Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res 1286: 1-12, 2009.
33. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43: 84-88, 1995.
34. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 88: 277-284, 2003.
35. Wada T, Pippin JW, Nangaku M, Shankland SJ. Dexamethasone's prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation. Nephron Exp Nephrol 109: e8-e19, 2008.
36. Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16: 2615-2625, 2005.
37. Wallace AD, Cidlowski JA. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276: 42714-42721, 2001.
38. Weiwad M, Edlich F, Kilka S, Erdmann F, Jarczowski F, Dorn M, Moutty MC, Fischer G. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins. Biochemistry 45: 15776-15784, 2006.
39. Westberry JM, Sadosky PW, Hubler TR, Gross KL, Scammell JG. Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51. J Steroid Biochem Mol Biol 100: 34-41, 2006.
40. Westhoff TH, van der Giet M. Tacrolimus in the treatment of idiopathic nephrotic syndrome. Expert Opin Investig Drugs 16: 1099-1110, 2007.
41. Wolf IM, Periyasamy S, Hinds T Jr, Yong W, Shou W, Sanchez ER. Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol 113: 36-45, 2009.
42. Xing CY, Saleem MA, Coward RJ, Witherden IR, Mathieson PW. Direct effects of dexamethasone on human podocytes. Kidney Int 70: 1038-1045, 2006.
43. Yan K, Kudo A, Hirano H, Watanabe T, Tasaka T, Kataoka S, Nakajima N, Nishibori Y, Shibata T, Kohsaka T, Higashihara E, Tanaka H, Watanabe H, Nagasawa T, Awa S. Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int 56: 65-73, 1999.
44. Yanagida-Asanuma E, Asanuma K, Kim K, Donnelly M, Young Choi H, Hyung Chang J, Suetsugu S, Tomino Y, Takenawa T, Faul C, Mundel P. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53: Mena signaling complexes in kidney podocytes. Am J Pathol 171: 415-427, 2007.
45. Zhang X, Clark AF, Yorio T. FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci 49: 1037-1047, 2008.